Author

Richard S. Hotchkiss

National Institutes of HealthORCID 0000-0002-5470-3655Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Andrew H. WaltoniD· 1 shared Anne M. DrewryiD· 1 shared Charles C. CaldwelliD· 1 shared Dale F. Osborne· 1 shared Dilip K. ToshiD· 1 shared Ethan Davitt· 1 shared Ivanna L. Rocha· 1 shared Jacqueline Unsinger· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Andrew H. WaltonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NeurosciencebioRxivPreprintSep 5, 2026

Low-Dose Interleukin-2 Resolves Stress-Induced Chronic Sensitization Independent of Opioid Receptor Signaling

Róli Rodrigues Simões, Scheila Kraus, Jintao Zhang…·Yuqing Q. Cao

This study identifies multiple pathways suppressing stress-induced chronic pain and shows low-dose IL-2 effectively resolves sensitization without relying on opioid or GABA signaling.

DOI 10.64898/2026.09.01.748528

mouseexperimental assay

𝕏 PostBluesky

ImmunologyScientific ReportsPeer-reviewedApr 18, 2025

Determining potential immunomodulatory drug efficacy in sepsis using ELISpot

Andrew H. Walton, Monty B. Mazer, Kenneth E. Remy…·Richard S. Hotchkiss

This study uses ELISpot to assess immunomodulatory drug effects on cytokine production in sepsis patients and healthy controls.

8 citationstop 5%

humanproteomics

𝕏 PostBluesky